“SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION”. 2018. Nirma University Journal of Pharmaceutical Sciences 5 (1): 41-58. https://doi.org/10.5281/.